ER Positive Braest Cancer and others By Rajiv Sarin
Session 2 : ER Positive Braest Cancer and others
Chairpersons :
Ramesh Nimmagadda, N K Warrier
Speaker :
Rajiv Sarin
A Phase III trial of adjuvant capecitabine in breast cancer patients with HER2-negative pathologic residual invasive disease after neoadjuvant chemotherapy( CREATE-X, JBCRG 04)
Author: Lee S-J
Conference: SABCS
Consensus on breast cancer cell lines classification for an effective and efficient clinical decision making
Author: H. Milioli
Conference: IMPAKT